for people ages 18 years and up (full criteria)
study started
estimated completion
William Cunningham (ucla)



Consistent treatment with anti-retroviral therapy (ART) suppresses viral load (VL), prolonging life and improving quality of life for HIV+ persons. Suppressing VL benefits communities by reducing transmission to others. Mere availability of ART and care, however, is insufficient; the benefits of ART depend upon HIV+ persons' continuous visits to the health care provider, regular monitoring and regular delivery of medications, - known as retention in HIV care. In spite of national efforts, up to a quarter of HIV+ persons, especially low-income minorities are out of care. Innovative interventions are therefore urgently needed to maximize engagement and retention in HIV care, self-reported adherence, as well as HIV-1 RNA viral load suppression. In pursuit of these aims, the proposed study will assess outcomes of the following interventions in comparison to usual care: 1) contingency management (CM) only; 2) peer navigation (PN) only; and 3) a combined approach that integrates both CM and PN (CA) which the investigators hypothesize to be most effective in improving HIV clinical outcomes.


HIV/AIDSCombined Contingency Management and Peer NavigationContingency ManagementPeer NavigationContingency Management onlyPeer Navigation only


You can join if…

Open to people ages 18 years and up

  1. Diagnosed HIV+
  2. Age 18 years or older
  3. English or Spanish speaking
  4. Residence in Los Angeles County
  5. prescribed ART in prior 24 months
  6. < 3 visits in prior 12 months or have detectable viral load, as identified in the Ryan White CaseWatch database

You CAN'T join if...

Not meeting any of the criteria identified above


  • Northeast Valley Health Corporation accepting new patients
    Van NuysCalifornia91401United States
  • Center for Health Justice accepting new patients
    Los AngelesCalifornia90012United States
  • Los Angeles Sheriff's Department accepting new patients
    Los AngelesCalifornia90012United States

Lead Scientist


accepting new patients
Start Date
Completion Date
University of California, Los Angeles
Study Type
Last Updated